ELAVL1 and cancer: Considering the importance of HuR in cancer development and progression, this RBP is considered a promising therapeutic target in cancer treatment, and preclinical studies, by using siRNAs to downregulate HuR, have shown the effectiveness of this approach in various types of cancer, including thyroid13,18–20.